Research Featuring Prism Neuro Technology

*

Research Featuring Prism Neuro Technology *

Research Validating Prism Neuro Technology

Prism Neuro technology is trusted by researchers and high-performance organisations around the world to objectively measure how the brain controls movement.
Independent studies and collaborations with the Massachusetts Institute of Technology, University of Canberra, NSW Institute of Sport, Hockey Australia, and others have validated the Prism Neuro Movement Control Assessment System (PN MCAS) as a reliable, portable, and scientifically robust tool for assessing proprioceptive, visual, vestibular, and autonomic function.

  • Researchers: NSW Institute of Sport & University of Canberra
    Conference Publication: European College of Sports Science, 2025

    Sixty-three Olympic and aspiring Olympic athletes completed sensorimotor testing using the Prism Neuro Movement Control Assessment System (MCAS). Podium-level athletes demonstrated greater proprioceptive accuracy and stronger visual tracking ability compared to their peers.

    Machine learning models built from these metrics correctly identified podium-level athletes with 92% accuracy, performing 2.2 times better than random selection. The findings highlight the value of combining sensorimotor data with predictive analytics to identify and develop elite performers.

    Key takeaway:
    Prism Neuro’s MCAS metrics provide objective markers of elite athletic potential, enabling evidence-based talent identification and performance optimization.

  • Researchers: University of Canberra
    Publication: European College of Sports Science, 2025

    This study assessed 120 community-level Australian Football athletes as part of pre-season baseline testing using the Prism Neuro MCAS. Athletes also completed a self-report survey on COVID infection and concussion history from the previous year.

    Results showed that athletes who reported prior COVID-19 infection demonstrated poorer autonomic responses than those reporting prior concussion or neither condition. Those with both COVID and concussion histories performed worse across all sensorimotor metrics, suggesting a compounding effect. Although this group was small, the pattern indicates that combined physiological stressors may have measurable, lingering effects on sensorimotor control.

    Key takeaway:
    Prism Neuro testing detected sensorimotor and autonomic differences linked to COVID and concussion history, supporting its use for monitoring residual effects of illness and injury in healthy athletes.

  • Researchers: University of Canberra
    Publication:Perceptual and Motor Skills, 2025

    Twenty-eight healthy participants aged 20–88 completed the Prism Neuro Movement Control Assessment System (MCAS) protocol twice to test reliability. The study examined seven key metrics—three reflexive and four involving voluntary control—and calculated intraclass correlation coefficients for each.

    Reflexive measures, such as visual and autonomic responses, showed strong repeatability, voluntary measures demonstrated moderate to good reliability. These results align with similar validated clinical tools and confirm the MCAS as a robust, repeatable system for assessing sensorimotor performance.

    Key takeaway:
    This research establishes the test–retest reliability of Prism Neuro’s MCAS metrics, confirming their suitability for clinical and performance applications that require consistent, repeatable measurements.